• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

mBio. A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine

Giuseppe

Emeritus
[Source: mBio, full page: (LINK). Abstract, edited.]

A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus

Harvey J. Alter<SUP>a</SUP>, Judy A. Mikovits<SUP>b</SUP>, William M. Switzer<SUP>c</SUP>, Francis W. Ruscetti<SUP>d</SUP>, Shyh-Ching Lo<SUP>e</SUP>, Nancy Klimas<SUP>f,g</SUP>, Anthony L. Komaroff<SUP>h</SUP>, Jose G. Montoya<SUP>i</SUP>, Lucinda Bateman<SUP>j</SUP>, Susan Levine<SUP>k</SUP>, Daniel Peterson<SUP>l</SUP>, Bruce Levin<SUP>m</SUP>, Maureen R. Hanson<SUP>n</SUP>, Afia Genfi<SUP>o</SUP>, Meera Bhat<SUP>o</SUP>, HaoQiang Zheng<SUP>c</SUP>, Richard Wang<SUP>a</SUP>, Bingjie Li<SUP>e</SUP>, Guo-Chiuan Hung<SUP>e</SUP>, Li Ling Lee<SUP>n</SUP>, Stephen Sameroff<SUP>o</SUP>, Walid Heneine<SUP>c</SUP>, John Coffin<SUP>p</SUP>, Mady Hornig<SUP>o</SUP>, and W. Ian Lipkin<SUP>o</SUP>
<SUP></SUP>

Author Affiliations: Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, USA<SUP>a</SUP>; Mikovits Consulting, Oxnard, California, USA<SUP>b</SUP>; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA<SUP>c</SUP>; Cancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA<SUP>d</SUP>; Tissue Safety Laboratory, Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA<SUP>e</SUP>; Nova Southeastern University, Fort Lauderdale Florida, USA<SUP>f</SUP>; Miami Veterans Affairs Medical Center, Miami, Florida, USA<SUP>g</SUP>; Brigham and Women?s Hospital, Boston, Massachusetts, USA<SUP>h</SUP>; Infectious Disease Clinic, Stanford University, Palo Alto, California, USA<SUP>i</SUP>; Fatigue Consultation Clinic, Salt Lake City, Utah, USA<SUP>j</SUP>; Levine Clinic, New York, New York, USA<SUP>k</SUP>; Simmaron Research Institute, Incline Village, Nevada, USA<SUP>l</SUP>; Department of Biostatistics, Columbia University, New York, New York, USA<SUP>m</SUP>; Department of Molecular Biology and Genetics, Cornell University, Ithaca, New York, USA<SUP>n</SUP>; Center for Infection and Immunity, Columbia University, New York, New York, USA<SUP>o</SUP>; and Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, USA<SUP>p</SUP>

Address correspondence to W. Ian Lipkin, wil2001@columbia.edu.

Editor Michael Buchmeier, University of California, Irvine



ABSTRACT

The disabling disorder known as chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) has been linked in two independent studies to infection with xenotropic murine leukemia virus-related virus (XMRV) and polytropic murine leukemia virus (pMLV). Although the associations were not confirmed in subsequent studies by other investigators, patients continue to question the consensus of the scientific community in rejecting the validity of the association. Here we report blinded analysis of peripheral blood from a rigorously characterized, geographically diverse population of 147 patients with CFS/ME and 146 healthy subjects by the investigators describing the original association. This analysis reveals no evidence of either XMRV or pMLV infection.



IMPORTANCE

Chronic fatigue syndrome/myalgic encephalomyelitis has an estimated prevalence of 42/10,000 in the United States, with annual direct medical costs of $7 billion. Here, the original investigators who found XMRV and pMLV (polytropic murine leukemia virus) in blood of subjects with this disorder report that this association is not confirmed in a blinded analysis of samples from rigorously characterized subjects. The increasing frequency with which molecular methods are used for pathogen discovery poses new challenges to public health and support of science. It is imperative that strategies be developed to rapidly and coherently address discoveries so that they can be carried forward for translation to clinical medicine or abandoned to focus resource investment more productively. Our study provides a paradigm for pathogen dediscovery that may be helpful to others working in this field.



Footnotes

H.J.A., J.A.M., and W.M.S. contributed equally to this work.

Citation Alter HJ, et al. 2012. A multicenter blinded analysis indicates no association between chronic fatigue syndrome/myalgic encephalomyelitis and either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus. mBio 3(5):e00266-12. doi:10.1128/mBio.00266-12.

Received 1 August 2012 - Accepted 20 August 2012 - Published 18 September 2012

Copyright ? 2012 Alter et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
- ------
 
Back
Top Bottom